Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-019809
Filing Date
2019-07-17
Accepted
2019-07-17 19:30:43
Documents
1
Period of Report
2019-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3388
  Complete submission text file 0000899243-19-019809.txt   5119
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 19960160
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations